Brink Marijke, Anwar Asif, Delafontaine Patrick
Division of Cardiology, Fondation pour Recherches Médicales, 64 Ave. de la Roseraie, CH-1205 Geneva, Switzerland.
Int J Cardiol. 2002 Sep;85(1):111-21, discussion 121-4. doi: 10.1016/s0167-5273(02)00239-5.
Mechanisms that lead to cachexia are still poorly understood. The neurohormonal changes that occur in severe disease states may cause an imbalance between protein synthesis and degradation at the cellular level, followed by muscle wasting. Here, we review actions of angiotensin II, TNF-alpha, corticosteroids, insulin-like growth factor-I (IGF-I), and the IGF binding proteins, factors that may each contribute to the metabolic imbalance. The complex endocrine, autocrine and intracellular interactions between these factors will be described with examples from patient, rat and cell culture studies. Moreover, some of the data supporting that each of these hormones may directly affect cellular protein degradation mechanisms will be reviewed. Knowledge on these regulatory mechanisms will facilitate the development of new pharmaceutical strategies to treat cachexia.
导致恶病质的机制仍未得到充分理解。严重疾病状态下发生的神经激素变化可能会导致细胞水平上蛋白质合成与降解之间的失衡,进而导致肌肉萎缩。在此,我们综述血管紧张素II、肿瘤坏死因子-α、皮质类固醇、胰岛素样生长因子-I(IGF-I)以及IGF结合蛋白的作用,这些因素可能各自导致代谢失衡。将通过患者、大鼠和细胞培养研究的实例来描述这些因素之间复杂的内分泌、自分泌和细胞内相互作用。此外,还将综述一些支持这些激素各自可能直接影响细胞蛋白质降解机制的数据。对这些调节机制的了解将有助于开发治疗恶病质的新药物策略。